1[1]McCully KS.Vascular Pathology of homocysteinemia:Implications for the pathogenesis of arteriosclerosis.Am J Pathol,1969,56:111-128
2[2]Coull BM,Malinow MR,Beamer N,et al.Elevated plasma homocysteine concentration as a possible indepentent risk factor for stroke.Stroke,1990,21:572
3[3]Houston PE,Rana S,Sekhsaria S,et al.Homocysteine in sickle cell disease:Relationship to stroke.Am J Med,1997,103:192-196
4[4]Frosst P,Blam H J,Milos R,et al.A candidate genetic risk factor for vascular disease:A common mutation in methylenete-trahydrofolate reductase.Nat Genet,1995,10:111-113
5[5]Weisberg I,Tran P,Christensen B,et al.A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR)associate with decreased enzyme activity.Mol Genet Metab,1998,64(3):169-172
6[6]Friedman G,Goldschmidt N,Friedlander Y,et al.A common mutation A1298C in human methylenetetrahydrofolate reductase gene:Association with plasma total homocysteine and folate concentrations.J Nutr,1999,129(9):1656-1661
7[7]Tsia MY,Gary U,Key NS,et al.Molecular and biochemical approaches in the identification of heterozgotes for homocysteinuria.Atherosclerosis,1996,122:69-77
9[9]Bousbey CJ,Beresford SA,Omenn GS,et al.A quantitative assessment of plasma homocysteine as a risk factor for vascular disease.JAMA,1995,272:1049-1057
10[10]Penix LP.Ischemic Stroke Secondary to Vitamin B12 deficiency-induced hyperhomocysteinemia.Neurology,1998,51:622-624
9Mckinley MC. Nutritional aspects and possible pathological mechanisms of hyperhomocysteinaemia : an independent risk factor for vascular disease[J]. Proc Nutr Soc,2000,59(2) :221.
10Finkelstein JD. The metabolism of homocysteine:pathways and regulation [J] .Eur J Pediatr, 1998,157[Suppl 2] :S40-S44.
